Literature DB >> 21800246

[Methodological challenges concerning the selection of diseases for a standardized multimorbidity index].

C Diederichs1, D B Bartels, K Berger.   

Abstract

Multimorbidity is defined as the coexistence of two or more chronic diseases. However, this complex health status, which primarily affects elderly, is still insufficiently understood. One reason is the underrepresentation of older, multimorbid people in studies. Another reason is that there is no agreement on the number and type of diseases, which have to be considered in the assessment of multimorbidity. Therefore, this article provides an overview on the status quo of research on multimorbidity indices and describes in detail, what kind of methodological challenges have to be faced regarding the development of a standardized index. Finally, recommendations are made for criteria, which can be used for the selection of diseases relevant for multimorbidity.

Entities:  

Mesh:

Year:  2011        PMID: 21800246     DOI: 10.1007/s00103-011-1323-0

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  2 in total

1.  Assessing and Measuring Chronic Multimorbidity in the Older Population: A Proposal for Its Operationalization.

Authors:  Amaia Calderón-Larrañaga; Davide L Vetrano; Graziano Onder; Luis A Gimeno-Feliu; Carlos Coscollar-Santaliestra; Angelo Carfí; Maria S Pisciotta; Sara Angleman; René J F Melis; Giola Santoni; Francesca Mangialasche; Debora Rizzuto; Anna-Karin Welmer; Roberto Bernabei; Alexandra Prados-Torres; Alessandra Marengoni; Laura Fratiglioni
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-10-01       Impact factor: 6.053

2.  How do patients with diabetes report their comorbidities? Comparison with administrative data.

Authors:  Jonas Hoffmann; Burkhard Haastert; Manuela Brüne; Matthias Kaltheuner; Alexander Begun; Nadja Chernyak; Andrea Icks
Journal:  Clin Epidemiol       Date:  2018-04-30       Impact factor: 4.790

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.